BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 18551025)

  • 1. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
    J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antihypertensive therapy on left atrial function.
    Dernellis JM; Vyssoulis GP; Zacharoulis AA; Toutouzas PK
    J Hum Hypertens; 1996 Dec; 10(12):789-94. PubMed ID: 9140783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
    Wachtell K; Papademetriou V; Smith G; Gerdts E; Dahlöf B; Engblom E; Aurigemma GP; Bella JN; Ibsen H; Rokkedal J; Devereux RB
    Am Heart J; 2004 Sep; 148(3):538-44. PubMed ID: 15389245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships of the appropriateness of left ventricular mass to left atrial size and function in arterial hypertension.
    Mureddu GF; Cioffi G; Stefenelli C; Boccanelli A
    J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):445-52. PubMed ID: 17502761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.
    Moon J; Rim SJ; Cho IJ; Lee SH; Choi S; Chung WJ; Byun YS; Ryu SK; Pyun WB; Kim JY
    Clin Exp Hypertens; 2010; 32(8):540-6. PubMed ID: 21091364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
    J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial systolic force: comparison between two methods for the noninvasive assessment of left atrial systolic function.
    Cioffi G; Chinali M; Mureddu GF; Stefenelli C; de Simone G
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):601-7. PubMed ID: 18475129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular mass and cardiac function in patients with essential hypertension.
    Grossman E; Oren S; Messerli FH
    J Hum Hypertens; 1994 Jun; 8(6):417-21. PubMed ID: 8089826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of central and general adiposity to abnormal left ventricular diastolic function in a community sample with a high prevalence of obesity.
    Libhaber CD; Norton GR; Majane OH; Libhaber E; Essop MR; Brooksbank R; Maseko M; Woodiwiss AJ
    Am J Cardiol; 2009 Dec; 104(11):1527-33. PubMed ID: 19932787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial size in children with hypertension: the influence of obesity, blood pressure, and left ventricular mass.
    Daniels SR; Witt SA; Glascock B; Khoury PR; Kimball TR
    J Pediatr; 2002 Aug; 141(2):186-90. PubMed ID: 12183712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial function assessed by real-time 3-dimensional echocardiography is related to right ventricular systolic pressure in chronic mitral regurgitation.
    Saraiva RM; Yamano T; Matsumura Y; Takasaki K; Toyono M; Agler DA; Greenberg N; Thomas JD; Shiota T
    Am Heart J; 2009 Aug; 158(2):309-16. PubMed ID: 19619710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study.
    de Simone G; Kitzman DW; Palmieri V; Liu JE; Oberman A; Hopkins PN; Bella JN; Rao DC; Arnett DK; Devereux RB
    Am J Hypertens; 2004 Sep; 17(9):828-33. PubMed ID: 15363827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced radial late systolic pressure augmentation in hypertensive patients with left ventricular hypertrophy.
    Hashimoto J; Watabe D; Hatanaka R; Hanasawa T; Metoki H; Asayama K; Ohkubo T; Totsune K; Imai Y
    Am J Hypertens; 2006 Jan; 19(1):27-32. PubMed ID: 16461187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-atrial conduction time shortens after blood pressure control in hypertensive patients with left ventricular hypertrophy.
    Fuenmayor AJ; Moreno G; Landaeta A; Fuenmayor AM
    Int J Cardiol; 2005 Jul; 102(3):443-6. PubMed ID: 16004889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.